A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT05036135 · TERMINATED

Trial details

NCT number: NCT05036135
Sponsor: Aerovate Therapeutics
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2021-12-02
Primary completion: 2024-08-09
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.